Medical Xpress·3 min read·medium
Blood-based test can predict risk of developing symptoms of Alzheimer's up to a decade early
M
Mass General Brigham
✦AI Summary
A new international study published in JAMA indicates that a blood test for the p-tau217 biomarker can predict the risk of cognitive impairment in healthy individuals up to a decade in advance. While promising, experts caution that the test is not currently recommended for asymptomatic individuals due to the lack of available disease-modifying treatments.
edited by Sadie Harley , reviewed by Andrew Zinin
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in